AIM
EMN icon

Acrospire Investment Management’s Eastman Chemical EMN Stock Holding History

Acrospire Investment Management’s Portfolio EMN Stock Details EMN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q3 		– Sell
-1,600
Closed -$134K – 458
2017
Q2 		$134K Buy
1,600
+1,500
+1,500% +$121K 0.13% 108
2017
Q1 		$8K Sell
100
-2,200
-96% -$173K 0.01% 1905
2016
Q4 		$173K Buy
2,300
+1,600
+229% +$116K 0.07% 469
2016
Q3 		$47K Sell
700
-400
-36% -$26.8K 0.03% 1106
2016
Q2 		$75K Sell
1,100
-400
-27% -$29.4K 0.06% 731
2016
Q1 		$108K Buy
+1,500
New +$98.3K 0.07% 278

Other funds holding EMN

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $46.4B AUM 27.74% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
O
OppenheimerFunds New York $80.4B AUM 15.1% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Acrospire Investment Management's EMN Position: Q3 2017 in Review

Acrospire Investment Management sold out of Eastman Chemical (EMN) in Q3 2017, closing a stake of 1,600 shares — an estimated $134K sold.

Acrospire Investment Management first reported a position in EMN in Q1 2016 and held it in 6 quarters. The position peaked at $173K in Q4 2016. 622 funds tracked by Wall St. Rank hold EMN as of Q3 2017.

  • Acrospire Investment Management reported no remaining Eastman Chemical position as of Q3 2017 after selling out during the quarter.
  • Acrospire Investment Management sold 1,600 Eastman Chemical shares in Q3 2017, an estimated $134K.
  • Acrospire Investment Management first reported a position in Eastman Chemical in Q1 2016 and held it in 6 quarters.
  • Acrospire Investment Management's Eastman Chemical position peaked at $173K in Q4 2016.
  • 622 funds tracked by Wall St. Rank held Eastman Chemical as of Q3 2017.

Based on Acrospire Investment Management's 13F filing for Q3 2017, filed 26 Oct 2017.